Korean J Blood Transfus.
1999 Dec;10(2):173-179.
Performance Evaluation of 'Dong-A Syphilis' EIA kit
- Affiliations
-
- 1Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center.
- 2Institute of Allergy and Clinical Immunology, Medical Research Center, Seoul National University Hospital.
- 3Blood Transfusion Research Institute, Korean National Red Cross.
- 4Dong-A Research Laboratory, Dong-A Pharmaceutical Co., Seoul, Korea.
Abstract
- BACKGROUND
'Dong-A Syphilis' enzyme immunoassay(EIA) kit for detecting antibodies against T. pallidum was recently introduced. The performance of 'Dong-A Syphilis' in precision, sensitivity and specificity was evaluated to know the adequacy in substituting for VDRL as a primary screening test.
METHODS
Intra and inter-run precision were evaluated by positive and negative controls and 4 other concentrations which were made by mixing positive controls with negative controls. Sensitivity and specificity were evaluated using 120 samples positive in both VDRL and FTA-ABS and using 487 samples negative in VDRL, respectively. Positive rates of EIA and VDRL among 342 persons who visited health promotion center in Asan Medical Center were compared.
RESLUTS: Intra-run precision was between 2.2% and 5.5%, and inter-run precision between 9.9% and 15.6%. Sensitivity and specificity were 99.2% and 99.7%, respectively. EIA showed higher positive rate (5.8%) than VDRL (3.5%). 11 samples (3.2%) were reactive only in both EIA and FTA-ABS.
CONCLUSION
The performance of 'Dong-A syphilis' EIA was so good in precision, sensitivity and specificty that the EIA kit could substitute for VDRL as a primary screening test for syphilis. EIA screening for syphilis would be more appropriate for a person to promote his own health in that it could detect untreated past infection.